ArticleJournal of acquired immune deficiency syndromes (1999)2025
Anticipated Protection Overcomes Vaccine Hesitancy and Mistrust Among Women Enrolled in the DC MACS/WIHS Combined Cohort Study.
Amanda Blair Spence, Adam Visconti, Lakshmi Goparaju, Gina Wingood, Sarah Krier, M Reuel Friedman, Seble Kassaye
Abstract read
In one paragraphArticle in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Amanda Blair SpenceDepartment of Medicine, Division of Infectious Disease and Tropical Medicine, Georgetown University, Washington, DC.ORCID 0000-0001-9011-8456 Adam ViscontiDepartment of Medicine, Division of Infectious Disease and Tropical Medicine, Georgetown University, Washington, DC.
Lakshmi GoparajuDepartment of Medicine, Division of Infectious Disease and Tropical Medicine, Georgetown University, Washington, DC.
Gina WingoodDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York City, NY.
Sarah KrierDepartment of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburg, PA; and.
M Reuel FriedmanDepartment of Urban-Global Public Health, School of Public Health, Rutgers University, Newark, NJ.
Seble KassayeDepartment of Medicine, Division of Infectious Disease and Tropical Medicine, Georgetown University, Washington, DC.
Funding
UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1MVirology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1MEngaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0MVirology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9MVirology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0MQAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7MMaternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8MUniversity of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Savita Pahwa · 2007 to 2026
$33.8MUniversity of Pittsburgh MWCCS Clinical Research SiteU01HL146208 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Bernard Jonas C Macatangay, CHARLES R RINALDO · 2019 to 2026
$32.2MPatient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Vinayaka R. Prasad · 2017 to 2026
$28.3MSurviving the HIV Epidemic (S/HE) in metropolitan Washington DC - Advancing knowledge through cohort studiesU01HL146205 · NHLBI · GEORGETOWN UNIVERSITY · PI SEBLE G KASSAYE, DANIEL J MERENSTEIN · 2019 to 2026
$23.5MInstitutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5MNational Institutes of Health Office of AIDS Research 3U01HL146208-03S1NCATS NIH HHS KL2 TR001432NCATS NIH HHS KL2TR001432NCATS NIH HHS TL1 TR001431NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR001409NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1 TR003098NHLBI NIH HHS U01 HL146205NHLBI NIH HHS U01-HL146205NHLBI NIH HHS U01 HL146208NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI073961NIAID NIH HHS P30 AI124414NIMH NIH HHS P30 MH116867
6 · The paper itselfAbstract
backgroundDespite efficacy of COVID-19 vaccines in preventing severe complications of infection, there remains vaccine hesitancy. We examined COVID-19 vaccine uptake and vaccine hesitancy among persons living with HIV (PWH).
methodsA nested survey was administered to women in the District of Columbia MACS-WIHS Combined Cohort Study (October 01, 2020-September 30, 2022). The survey included questions on vaccine receipt, medical mistrust, government trust, and vaccine attitudes. Sociodemographic and medical comorbidity data were collected at routine study visits.
resultsAmong 254 women, 75% (n = 190) were African American/Black, and 70% (n = 178) were PWH, and 82% (n = 208) received a complete COVID-19 vaccine series. Vaccine completion rate was similar among PWH and women without HIV. The top reasons for a participant's vaccine decision were personal choice 46% (n = 113), health care provider recommendation 24% (n = 60), and family influence 31% (n = 13). Sixty-five percent (n = 159) endorsed concern about unknown vaccine side effects. The mean medical mistrust score was 32.4 (SD 3.8, range 12-60, higher scores indicate more mistrust). In adjusted analysis, older age [aOR = 1.05 (95% CI: 1 to 1.1, P = 0.032)], prior testing for COVID-19 [aOR = 3.50 (95% CI: 1.23 to 9.99, P = 0.019)], and feeling protected after being vaccinated [aOR = 4.65 (95% CI: 1.98 to 10.91, P < 0.001)] were associated with receipt of COVID-19 vaccines. There was no association between medical mistrust [aOR = 1.01 (95% CI: 0.95 to 1.06, P = 0.87)] or concerns about vaccine safety [aOR = 0.57 (95% CI: 0.26 to 1.28, P = 0.17)] and receipt of COVID-19 vaccines.
conclusionsConcern about potential risks associated with vaccines remains a significant challenge. Interventions emphasizing protective benefits of vaccines using shared decision making may be useful for public health campaigns.
Indexed as
COVID-19COVID-19 VaccinesHIV InfectionsTrustVaccination HesitancyAdultCohort StudiesDistrict of ColumbiaFemaleHumansMiddle AgedSARS-CoV-2Surveys and QuestionnairesCOVID-19 VaccinesCOVID-19HIVmedical mistrustvaccine hesitancywomen with HIV
Identifiers
PMID40900131
PMCPMC12869428
What Socratic holds
Textmetadata
LicenceTDM
Read underepoch 390